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Abstract
Background
Improving patient care for individuals with lung cancer is a priority due to the increasing burden of the
 disease globally. One way this can be done is by improving patient self-management capabilities through
 increasing their self-efficacy. This can improve positive outcomes for patients with chronic conditions and
 increase their ability to manage the challenges of such illnesses. Unfortunately, patients with chronic
 conditions often struggle to travel far from home to engage with patient education events, a common means
 of improving self-efficacy. The development of more accessible tools for improving patient self-efficacy is
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 required to increase quality of life for patients with chronic conditions.
Objective
To evaluate the feasibility of delivering symptom identification and management information to patients
 with advanced lung cancer using an online program.
Methods
This article describes a pre-post test study to evaluate a Qstream online learning platform to improve patient
 self-efficacy for managing advanced lung cancer symptoms. Undertaking this program should increase
 participant knowledge about the side-effects they may experience as a result of their treatment and in turn
 increase help-seeking behavior and self-efficacy for the participant cohort. Quantitative data collected by
 the Qstream platform on the completion rates of participants will be used as a tool to evaluate the
 intervention. Additionally, validated scales will be used to collect data on patient self-efficacy. Qualitative
 data will also be collected via an exit survey and thematic content analysis of semi-structured interviews.
Results
The research is in the preliminary stages but thus far a protocol has been approved in support of the project.
 Additionally, advisory committee members have been identified and initial meetings have been undertaken.
Conclusions
Development of new approaches for increasing patient understanding of their care is important to ensure
 high quality care continues to be delivered in the clinical setting.
Keywords: patient education, eHealth, online learning, lung cancer, palliative care, side-effect
 management, patient safety and quality, patient self-efficacy
Introduction
In 2012, 1.82 million people globally were diagnosed with lung cancer, making it the most commonly
 diagnosed cancer [1]. The World Health Organization predicts that by 2020 that number will increase to 2.2
 million [2]. In Australia, nearly 80% of lung cancers are diagnosed at an advanced stage when prognosis is
 poor, and the overall survival rate is only 15% [3]. These patients often experience multiple symptoms as a
 result of their disease and/or treatment, including unrelieved pain, breathlessness, distress, and nausea and
 vomiting [4-5]. Appropriate management of these symptoms is important due to the negative impact on
 patients, which may include hospitalization if these symptoms are poorly controlled [6].
Managing symptoms in the community requires patients and their caregivers to have good self-management
 capabilities to ensure they are capable of optimally handling both pharmacological and nonpharmacological
 interventions. Factors that reduce patient self-efficacy include low health literacy and lack of involvement
 in treatment decision making. This is particularly concerning considering the literature has shown that both
 health literacy and involvement in shared decision making significantly impact patient satisfaction and
 treatment outcomes [7]. There is also evidence that patients with lung cancer may have a diminished
 understanding of their illness and prognosis and less support in facing end-of-life issues [3]. As a result,
 these patients are less likely to be proactive in symptom management or demonstrate help-seeking
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 behaviors that could improve their quality of life.
The ability of patients to self-manage aspects of treatment is important because it has been shown to
 improve outcomes for patients. Doing so can also increase the likelihood patients will successfully manage
 the challenges of chronic illness [8-9]. One approach to doing this is through the delivery of face-to-face
 patient education programs. However, these programs could also be delivered online, increasing
 accessibility for patients unwilling or unable to attend patient education events as a result of their condition.
 Additionally, there is evidence to suggest an online self-management program can impact self-care and
 health behaviors in patients [10].
This protocol describes a methodology designed to develop and evaluate a new approach to increasing
 disease literacy and help-seeking behavior in patients, a high priority for clinicians and patients alike [11].
 In addition to the potential benefit of reducing hospital use costs, earlier treatment of side-effects resulting
 from better patient education may lead to patients receiving more of their planned therapy. A phase I
 feasibility study design is being used to evaluate the impact of an online learning program on self-efficacy
 and help-seeking behavior in patients with advanced lung cancer. The project aims to improve the quality
 of life for these patients by increasing their ability to identify and manage symptoms of their treatment.
Methods
Aims
The proposed study evaluates the feasibility of delivering an online self-efficacy program to patients with
 advanced lung cancer using an online education platform. This program will provide patients with relevant
 information to identify symptoms resulting from their treatment and provide them with strategies to manage
 these symptoms when they occur. Additionally, the study aims to assess the impact of the intervention on
 patient self-efficacy and help-seeking behavior.
In the context of this study, feasibility, including whether the patient population will complete a self-
efficacy program delivered online, is being evaluated from the perspective of the patient and not the clinical
 organization. Additionally, the study will look at whether participants found the program beneficial for
 identifying and managing their treatment symptoms. This will be evaluated using semistructured
 interviews.
Design
A pre-post test design is being used to evaluate an online learning program for improving patient self-
efficacy in managing symptoms of treatment for advanced lung cancer. Use of the program should increase
 participant knowledge about side-effects they may experience and in turn increase help-seeking behavior
 and self-efficacy for the patient cohort. The online module in this study will be delivered on the Qstream
 spaced education platform.
Qstream is an evidence-based form of online education that has been shown to improve knowledge
 acquisition, enhance knowledge retention, and change behavior [12]. Participants in Qstream courses
 receive repeating, short, case-based questions as well as expert feedback via email in a reinforcing pattern
 over a number of weeks. The methodology is based on two core psychological research findings: the
 spacing and testing effects. The spacing effect refers to the finding that educational encounters repeated
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 over time increase the acquisition and retention of knowledge. The testing effect refers to the finding that
 the process of testing not only measures knowledge but also improves retention [13-14].
The Qstream spaced learning platform has repeatedly been shown in medical professional development to
 impact learner knowledge, resulting in behavior change [15]. However, its utility as a tool for engaging
 with patients has yet to be explored. Existing research on health literacy has shown that improving patients’
 knowledge about their treatment can positively impact on quality of life by reducing anxiety and mood
 disturbances [16]. However, current interventions aimed at improving patient knowledge about treatment
 side-effects are often either health provider–focused applications or passive dissemination of information in
 written or Web-based materials [17]. In this study, the Qstream platform will be used for dissemination of
 key information in a dynamic, personalized, and active manner.
Based on the current research into Qstream as a tool for knowledge dissemination and reinforcement, there
 is reason to believe it has potential as a means of improving self-efficacy for cancer patients [12]. In
 addition, the platform has been shown to be easily accessible to learners due to its ability to deliver short,
 focused pieces of key information at times that suit the learner [18], making the platform adaptable to
 individual patient information needs.
Quantitative data collected by the Qstream platform on the completion rates of participants will be used as a
 tool to evaluate the intervention. Additionally, validated scales will be used to collect data on patient self-
efficacy. Qualitative data will also be collected via a survey at the conclusion of the module and thematic
 content analysis of semistructured interviews.
Setting
This study will be undertaken within the Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney,
 Australia, which runs a dedicated clinic to support patients with a new diagnosis of lung cancer.
Study Inclusion and Exclusion Criteria
Eligible participants will be age 18 years or older with a new diagnosis of stage II to stage IV lung cancer
 and a life expectancy greater than three months. Additionally, participants will need access to an Internet
 connection and a level of spoken and written English adequate to understand the Qstream cases. Patients
 who are considered too physically or mentally unwell to participate in the study, do not have adequate
 English skills, or do not have access to the Internet will be excluded from this study.
A clinical nurse consultant experienced in supporting patients with advanced lung cancer will meet with
 potential participants to assess their eligibility. This identification process is being used instead of
 alternative methods such as the Eastern Cooperative Oncology Group (ECOG) status or treatment
 algorithm due to the difficulty of determining whether patients are physically well enough to participate in
 the study.
Study Recruitment
The research team aims to recruit 60 patients from the new lung cancer clinic between January and June
 2016. Given that approximately 40 new patients are referred every month, we estimate it will take six
 months to recruitment 60 patients. This cohort size accounts for an attrition rate of 30%, consistent with
 other online programs [19].
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Developing the Side-Effect Management Online Learning Module
A brief review of the literature will be undertaken to identify which key symptoms, such as pain
 management or constipation, are identified as having significant quality-of-life impact for patients with
 advanced lung cancer. The identified symptoms will inform the focus of the side-effect management
 program. In addition to a literature review, a local retrospective record audit of between 40 and 60 patients
 who attended the new lung cancer patient clinic at Westmead Hospital will be undertaken. The local audit
 will review the symptom burden in the local population to ensure it aligns with the literature.
To oversee the development of the side-effect management program, an expert advisory committee will be
 convened with representatives from a range of clinical disciplines including at least one representative from
 the medical oncology, nursing, and palliative care services. This advisory group will have a central role in
 determining the key messages of the online program, which will be used to develop cases for the Qstream
 platform. Additionally, the advisory committee will review and prioritize the key domains that the side-
effect management program will address.
The Qstream program will consist of approximately one dozen cases in order to convey necessary
 information. Cases will be developed in two different categories: symptom identification and symptom
 management, including when to seek medical assistance. Cases will have a consistent format and include an
 example of a common event encountered as part of lung cancer treatment along with advice on how to
 address this scenario. In each key symptom domain, there will be a case example guiding participants
 through identification of a symptom and when and how to seek help if a symptom is unmanageable.
For each case, participants will be given a choice of options for how to respond to the situation, of which
 they will select one. Once participants have selected an option they will be shown how their response
 compares to other participants undertaking the program. All participants will be given aliases to use in the
 Qstream platform to ensure patient confidentiality is maintained. In addition to presenting responses of
 other participants, each case will contain video feedback from a member of the lung cancer team at
 Westmead Hospital to reinforce the correct approach in a friendly, accessible, and personalized manner.
 Finally, written feedback will be provided along with links to further resources for participants to explore if
 they wish. See Figure 1 for a flow chart of patient movement through the Qstream program.
Implementing the Side-Effect Management Online Learning Module
Once the side-effect management module has been completed it will be made available to study participants.
 All participants will be automatically enrolled in the Qstream program and receive cases via email or
 smartphone in the following manner:
1. Each participant will be sent an email every 2 days containing at least 2 questions.
2. If they answer a question incorrectly, it will be re-sent 5 days later.
3. If they answer a question correctly, the question will be re-sent 8 days later.
4. If a question is answered correctly twice in a row, the question will be retired.
5. The course will be completed once all questions have been retired.
We anticipate that most participants will take between 4 and 6 weeks to complete the Qstream program.
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Baseline Data Collection
Self-Efficacy for Managing Chronic Disease 6-Item Scale
Online Technologies Self-Efficacy Scale
Lerman Perceived Involvement in Care Scale
Eastern Cooperative Oncology Group Score
Symptom Diary
Evaluating the Side-Effect Management Online Learning Module
Baseline data will be collected for the study prior to the dissemination of the
 Qstream intervention. The research team will use validated surveys to collect information on participant
 self-efficacy, technical literacy, and involvement in care.
Six weeks after completion of the course, participants will be asked to repeat the survey and answer a
 number of questions evaluating the Qstream program. Additionally, patients will be invited to participate in
 an endpoint semistructured interview to evaluate their perception of the impact of the course on their self-
efficacy and quality of life. See Table 1 for the tools being used to collect data throughout the study and the
 time points at which they are being used.
Finally, metrics collected routinely by the Qstream platform will be reviewed to determine usage of the
 program. A particular focus will be on the number of participants who complete the program and how
 many cases were completed by participants who do not.
The Self-Efficacy for Managing Chronic Disease
 6-Item Scale [20], developed by the Stanford Patient Education Research Center, will be used to rate
 participants across several domains common in chronic disease including emotional functioning and
 symptom control. The scale is based on a larger self-efficacy scale developed for the Chronic Disease Self-
Management Study [21].
The scale requires respondents to rate 6 items on a scale of 1 to 10, where 1 indicates “not at all confident”
 and 10 indicates “totally confident.” The scale was tested on a cohort of 244 individuals with chronic
 disease: the mean score was 30.24, with a standard deviation of 6.28 and internal consistency reliability
 (Cronbach alpha) of .93 [20]. Although the tool has not been used with lung cancer patients, it has been
 used to measure self-efficacy in breast cancer patients [22].
To evaluate the technical literacy of participants, the Online
 Technologies Self-Efficacy Scale will be used. The validated scale was developed in 2000 to assess
 respondent confidence across a range of domains including use of email, use of Web browsers, and
 navigation of websites [23]. The scale was tested on a cohort of 330 tertiary level students. The Cronbach
 alpha is .95.
The final validated scale being used is the Lerman Perceived
 Involvement in Care Scale (PICS). This tool will be used to collect baseline data on participant perception
 of involvement in their care. The PICS has 13 items that were validated using a test cohort of 131
 individuals. The Cronbach alpha is .73. An alpha coefficient of .60 was determined using an independent
 sample of 81 patients [24]. This tool has been used effectively with a number of patient populations
 including a group of 1081 early stage breast cancer patients [25].
The ECOG score will used to collect baseline data regarding
 disease progression and other treatment information. Information for this ranking, along with basic
 demographic data such as gender, age, and postal code, will be obtained from the patient medical record.
To minimize recall error, participants will be asked to keep a diary to capture incidences of
 symptoms that occur during the intervention [26]. Study participants will be provided with a prestructured
 diary booklet to use as a guideline that includes instructions on what to include in entries and an example of
 an entry. The booklet will be accompanied by a cover letter reenforcing the outline and the disease-specific
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 information to be included. Contact information will be provided for participants who have questions. At
 the conclusion of the study period, the diary will be evaluated for feasibility as a measurement tool and
 influence of the intervention on symptom management. The diary entries may be discussed with patients in
 a later interview.
Data Analysis
The primary goal of this study is to assess the feasibility of delivering treatment self-management
 information to patients using the Qstream platform. Quantitative data collected by the platform will be
 analyzed to gain insight into the uptake and completion rates of the program by the study participants.
 Additionally, qualitative data will be analyzed to measure the impact of the program on symptom
 management knowledge, self-efficacy, and help-seeking behaviour.
Quantitative data on patient self-efficacy is being collected via a validated survey administered at two time
 points: two weeks prior to intervention and two weeks postintervention. All data analysis will be performed
 using SPSS statistical analysis software (IBM Corp). The after minus before difference will be measured
 for each patient who completes both the pre- and postsurvey. The average of the before/after difference will
 be determined to test the hypothesis that the difference is not zero. A matched t test will be used at a level
 of significance set at 0.05. The difference (as a 95% confidence interval) and the P value will be presented.
Qualitative data is being collected through semistructured interviews with participants. This data will be
 thematically analyzed to identify emergent and overarching themes with characteristic quotes used to
 exemplify each theme. Two researchers will read each transcript and independently create a draft coding
 scheme. This will be discussed, and any differences will be resolved in consultation with the wider research
 team. Additional transcripts will be read with iterative refinement of the draft coding scheme. An
 appropriate software program will be used to organize the data and allow development of themes,
 subthemes, and higher order themes, with characteristic quotes. The final thematic summary will be sent to
 a subset of participants who will be phoned for feedback on the accuracy of this summary.
Ethical and Legal Considerations
As of January 2016, the protocol has been granted ethical approval by the Western Sydney Local Health
 District Human Ethics Committee. To obtain ethical approval this study was evaluated for compliance with
 the National Statement on Ethical Conduct in Human Research 2007 and the National Health and Medical
 Research Council guidelines under Section 95 of the Privacy Act 1988.
Data Storage Procedure
All data collected from participants will be deidentified and coded with a participant identification code on a
 master log sheet by a member of the research team. Participant codes will be kept in a password-protected
 Excel spreadsheet on a password-protected electronic database. Only deidentified information will be used
 by members of the research team when data analysis is being undertaken.
Information collected for, used in, or generated by this project will remain securely stored in the offices of
 the principle investigator. For digital information, this will involve storage password-protected personal
 computers. Paper copies will have identifiers removed and will be stored in a locked filing cabinet.
Potential Risks
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There is a risk that some participants may experience distress during this study. Participants will be
 provided access to a counseling service if they are experiencing distress. Information on how to contact the
 counseling service will be provided to participants when they register for the study. Loss of confidentiality
 is an additional risk of this study. Researchers are minimizing this risk by following the data storage
 procedure outlined earlier in this protocol.
Results
This protocol describes a research study in its preliminary stages and, as such, only modest results can be
 reported. One significant outcome is the development of a comprehensive method for evaluating the impact
 of a online program for delivering symptom identification and management information to patients.
An expert advisory committee including medical oncologists, palliative care specialists, and clinical nurse
 consultants has been identified and convened to guide the direction of this project. Initial consultation with
 the advisory committee has identified symptoms that will be targeted by the Qstream program. The
 advisory committee has decided pain management, breathlessness, constipation, nausea, and lethargy would
 be the most relevant areas to address for the patient population in this study. All of these symptoms are
 identified in the literature as being challenging for patients to self-manage.
Discussion
Prinicipal Findings
The development of tools to support patient self-efficacy in managing advanced lung cancer is important
 due to the significant burden cancer represents globally [1]. Although interventions exist to improve patient
 health literacy and increase patient involvement in their care, these interventions largely focus on passive
 dissemination of information [17]. This research protocol explores an online knowledge dissemination
 module that has been demonstrated to impact both knowledge and behavior [12]. The Qstream platform has
 not previously been used for patient education but has been used extensively for delivering health education
 to other groups [15]. As a result, the findings of this study contribute to addressing a clear gap in the current
 literature.
Although the program is being evaluated in the context of lung cancer, it has potential to be used across a
 range of other cancers and chronic conditions. The literature on symptom prevalence for patients with
 advanced lung cancers shows that patients with this condition experience nausea and vomiting, and
 symptoms resulting in patient hospital admission include pain and dyspnea [6]. These symptoms are not
 unique to lung cancer and are prevalent across chronic conditions including heart disease, AIDS, and renal
 disease [27]. If the intervention is effective with patients with lung cancer it may be applicable across a
 much broader patient population.
Finally, in order to ensure a high quality of care continues to be delivered to patients, the evaluation of new
 techniques for dissemination of patient information is a priority. Unfortunately the literature to date
 suggests that there is a gap in knowledge relating to the identification and uptake of appropriate behavior
 change techniques to promote such behaviors in patients [28]. By evaluating the impact of Qstream on
 patient self-efficacy and help-seeking behavior we anticipate that a significant contribution will be made to
 address this gap in the literature.
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Conclusions
Developing and evaluating new techniques for dissemination of patient information to enhance patient self-
efficacy and understanding of their care is integral for ensuring high quality care continues to be delivered
 in the clinical setting. This is particularly important for treatment of chronic conditions such as advanced
 lung cancer, because optimal delivery of such information can improve patient self-efficacy and ensure a
 high quality of life is maintained during end-of-life care.
Abbreviations
ECOG Eastern Cooperative Oncology Group
PICS Perceived Involvement in Care Scale
Footnotes
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A flow chart showing how patients work through the Qstream program.
Table 1





Self-Efficacy for Managing Chronic Disease 6-Item
 Scale
X X
Online Technologies Self-Efficacy Scale (OTSES) X
Lerman Perceived Involvement in Care Scale (PICS) X
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